MAKOVY 200/25 contains two active substances:
- emtricitabine, an antiretroviral medicine of a type known as a nucleoside reverse transcriptase inhibitor (NRTI)
- tenofovir alafenamide, an antiretroviral medicine of a type known as a nucleotide reverse transcriptase inhibitor (NtRTI)
MAKOVY 200/25 blocks the action of the reverse transcriptase enzyme, which is essential for the virus to multiply. MAKOVY 200/25 therefore reduces the amount of HIV in your body. MAKOVY 200/25 in combination with other medicines is for the treatment of human immunodeficiency virus 1 (HIV-1) infection in adults and adolescents 12 years of age and older, who weigh at least 35 kg.